TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis
Cancer Medicine · 2025
DOI: 10.1002/cam4.71115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Abdou Malik Da Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imagi…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Histiocytosis, Langerhans-Cell, Telomerase, Promoter Regions, Genetic. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRTK.
Abstract (Originalsprache)
Background
In various malignancies, the co‐occurrence of BRAF V600E and TERT promoter mutations (C228T and C250T) has been associated with tumor aggressiveness and poor prognosis. However, the presence of these TERT promoter mutations in Langerhans cell histiocytosis (LCH) remains unexplored.
Methods
We investigated the prevalence of TERT promoter C228T and C250T mutations in 40 formalin‐fixed, paraffin‐embedded (FFPE) LCH samples positive for BRAF V600E. A nested PCR approach followed by Sanger sequencing, complemented by NGS, was used for mutation screening.
Results
The variant allele frequency (VAF) of BRAF V600E in the analyzed samples ranged from 0.1% to 33.6%, with a median of 17%, and 33 of 40 successfully amplified LCH samples did not harbor TERT C228T or C250T mutations.
Conclusion
Our findings indicate that LCH BRAF V600E‐positive samples lack the TERT promoter C228T and C250T hotspot mutations. This suggests that TERT promoter mutations may not play a significant role in LCH pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France.
ORCID-Profile: Abdou Malik Da Silva, Jean-François Emile
Förderung
- PRTK
Zitieren
APA
Silva, A. M. D., Hélias-Rodzewicz, Z., Ungureanu, I., & Emile, J. F. (2025). TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis. Cancer Medicine. https://doi.org/10.1002/cam4.71115
Vancouver
Silva AMD, Hélias-Rodzewicz Z, Ungureanu I, Emile JF. TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis. Cancer Medicine. 2025. doi:10.1002/cam4.71115
BibTeX
@article{Silva2025,
author = {Silva, Abdou Malik Da and Hélias-Rodzewicz, Zofia and Ungureanu, Irena and Emile, Jean-François},
title = {TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71115}
}
EUVIMED